Literature DB >> 26847883

Draft Genome Sequence of a Pseudomonas aeruginosa Strain Able To Decompose N,N-Dimethyl Formamide.

Lingyue Yan1, Ming Yan2, Lin Xu2, Li Wei3, Liting Zhang3.   

Abstract

Pseudomonas aeruginosa is a Gram-negative bacterium, which uses a variety of organic chemicals as carbon sources. Here, we report the genome sequence of the Cu1510 isolate from wastewater containing a high concentration of N,N-dimethyl formamide.
Copyright © 2016 Yan et al.

Entities:  

Year:  2016        PMID: 26847883      PMCID: PMC4742680          DOI: 10.1128/genomeA.01609-15

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Pseudomonas aeruginosa, which is infectious to plants (1, 2) and animals (3, 4), including human beings (5–7), is widely studied for its multidrug resistance (8–11). It is also used to degrade organic chemicals in wastewater because it can utilize a large range of organic chemicals as carbon sources (12–14) and survive in the presence of multiple metal ions (15–18). N,N-dimethyl formamide, an industrial organic solvent, possesses hepatotoxicity, embryotoxicity, teratogenicity, and possible carcinogenicity (19), but it is difficult to degrade. Here, we present the draft genome sequence of a wild-type strain of P. aeruginosa capable of degrading N,N-dimethyl formamide. The Cu1510 isolate was selected from wastewater with M9-N,N-dimethyl formamide (DMF) medium containing 10% N,N-dimethyl formamide (the only carbon source) and then cultivated in the LB medium at 37°C overnight. Genomic DNA of Cu1510 was extracted according to the instructions of a Biomiga bacterial genomic DNA (gDNA) kit (product no. GD2411-01). The quality and quantity of DNA were assayed using a K5500 microspectrophotometer (Kaiao) and agarose gel electrophoresis. Genome sequencing was performed at CapitalBio Technology using Illumina technology with a DNA sequencing (DNA-seq) paired-end protocol. A library was prepared with the NEBNext Ultra DNA library prep kit for Illumina, and the instrument used for sequencing was HiSeq 2500. The resulted 15 million reads were assembled with Velvet 1.1 (20) and then refined with SEQuel version 1.0.2 (21). The remaining contigs were submitted to the ProDeGe website (22) for automatic decontamination. e-RGA (23) was applied for genome mapping. The resulting 6,122,906-bp draft genome containing 5,336 genes is rich in G+C content (66.65%). Finally, the assembled sequence was submitted to the National Center for Biotechnology Information (NCBI) Prokaryotic Genome Annotation Pipeline (PGAP) (24) for annotation. A detailed analysis on the P. aeruginosa pathway of DMF biodegradation will be presented in a later essay.

Nucleotide sequence accession numbers.

The genome project was submitted to DDBJ/EMBL/GenBank under the accession no. CP013144. The version described in this paper is the first version, CP013144.1.
  19 in total

1.  Velvet: algorithms for de novo short read assembly using de Bruijn graphs.

Authors:  Daniel R Zerbino; Ewan Birney
Journal:  Genome Res       Date:  2008-03-18       Impact factor: 9.043

Review 2.  Iron uptake and metabolism in pseudomonads.

Authors:  Pierre Cornelis
Journal:  Appl Microbiol Biotechnol       Date:  2010-03-30       Impact factor: 4.813

3.  SEQuel: improving the accuracy of genome assemblies.

Authors:  Roy Ronen; Christina Boucher; Hamidreza Chitsaz; Pavel Pevzner
Journal:  Bioinformatics       Date:  2012-06-15       Impact factor: 6.937

4.  Uranium biomineralization by a metal resistant Pseudomonas aeruginosa strain isolated from contaminated mine waste.

Authors:  Sangeeta Choudhary; Pinaki Sar
Journal:  J Hazard Mater       Date:  2010-11-09       Impact factor: 10.588

5.  Characterization by phenotypic and genotypic methods of metallo-β-lactamase-producing Pseudomonas aeruginosa isolated from patients with cystic fibrosis.

Authors:  Yongwei Li; Xiaoqian Zhang; Chunxia Wang; Yue Hu; Xiaobin Niu; Dongxu Pei; Zhiqiang He; Yongyi Bi
Journal:  Mol Med Rep       Date:  2014-10-16       Impact factor: 2.952

6.  Mechanisms of plant growth promotion and disease suppression by Pseudomonas aeruginosa strain 2apa.

Authors:  P Hariprasad; S Chandrashekar; S Brijesh Singh; S R Niranjana
Journal:  J Basic Microbiol       Date:  2013-05-17       Impact factor: 2.281

Review 7.  Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis.

Authors:  Helle Krogh Johansen; Peter C Gøtzsche
Journal:  Cochrane Database Syst Rev       Date:  2008-10-08

Review 8.  The increasing threat of Pseudomonas aeruginosa high-risk clones.

Authors:  Antonio Oliver; Xavier Mulet; Carla López-Causapé; Carlos Juan
Journal:  Drug Resist Updat       Date:  2015-08-10       Impact factor: 18.500

9.  In Vitro Efficacy of Doripenem against Pseudomonas aeruginosa and Acinetobacter baumannii by E-Test.

Authors:  Mehreen Gilani; Tehmina Munir; Mahwish Latif; Sabahat Rehman; Maliha Ansari; Amira Hafeez; Sara Najeeb; Nadia Saad; Mehwish Gilani
Journal:  J Coll Physicians Surg Pak       Date:  2015-10       Impact factor: 0.711

10.  Removal of toxic Co-EDTA complex by a halophilic solar-salt-pan isolate Pseudomonas aeruginosa SPB-1.

Authors:  A Paraneeiswaran; Sudhir K Shukla; T Subba Rao; K Prashanth
Journal:  Chemosphere       Date:  2013-10-31       Impact factor: 7.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.